[Determination of neurometabolism in patients with mild and moderate cognitive impairments].

Objective: To estimate the diagnostic value of neuropower mapping (NPM) and positron emission tomography (PET) and their relationships in the evaluation of neurometabolism in patients with predementia cognitive impairments. MATERIAL AND METHODS. The investigation enrolled 125 patients wvith clinical signs of cognitive impairments.